Exagen Inc. (XGN) Tops Q4 EPS by 12c
Tweet
Share
E-mailGet Alerts XGN Hot Sheet
Join SI Premium – FREE
Exagen Inc. (NASDAQ: XGN) reported Q4 EPS of ($0.20), $0.12 better than the analyst estimate of ($0.32). Revenue for the quarter came in at $13.66 million versus the consensus estimate of $14.17 million.
For earnings history and earnings-related data on Exagen Inc. (XGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Frequency Electronics (FEIM) Misses Q4 EPS by 89c
- Jefferies Downgrades Nutrien (NTR) to Hold
- Citi reiterates Buy rating on Lumentum with $1,100 target, Opens Catalyst Watch
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
